Type 2-diabetes - Sundhedsstyrelsen

Antikoagulerende farmaka
Patient/problem: type 2 diabetes, NIDDM, diabetes mellitus non insulin dependent,
patient compliance, patient adherence, attitude to health
Intervention: anticoagulants, patient education, health care economics and organizations,
costs and cost analysis, NOT cost of illness
Sammenligning: change of lifestyle, diet therapy, chronic disease, self-care
Effektmål: mortality, morbidity, quality of life
Kombinationer af ovenstående
Patient/problem: type 2 diabetes, NIDDM, diabetes mellitus non insulin dependent,
patient compliance, patient adherence, attitude to health
Intervention: hypoglycemic agents, antidiabetics, hyperlipidemia, antihypertensive
agents, anticoagulants, patient education, health care economics and organizations,
costs and cost analysis NOT cost of illness
Sammenligning: change of lifestyle, diet therapy, chronic disease, self-care
Effektmål: mortality, morbidity, quality of life
Inklusionskriterier: Epidemiologiske og kliniske undersøgelser, artikler på
europæiske sprog
Eksklusionskriterier: Kasuistiske meddelelser
Kapitel 6: Diagnostik og screening for senkomplikationer til type 2-diabetes
Informationskilder
Medline, Embase, Healthstar, Science Citation Index, Social Science Citation
Index, PsycINFO, CINAHL, The Cochrane Library, DARE, NHS Economic
Evaluation Database, HTA Database, Diabetesforeningen, Hjerteforeningen,
American Diabetes Association, DSI Bib
Søgestrategier
Der er søgt med følgende kontrollerede og frie termer i forskellige kombinationer:
Retinopati
Patient/problem: type 2 diabetes, NIDDM og diabetes mellitus non insulin dependent
Intervention: screening, early detection, mass screening, high risk screening
Effektmål: vision, blindness, diagnosis, morbidity, predictive value of tests, patient
compliance, cost effectiveness
Nefropati
Patient/problem: type 2 diabetes, NIDDM og diabetes mellitus non insulin dependent
308 Type 2-diabetes. Medicinsk teknologivurdering af screening, diagnostik og behandling